Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Letter by Urra et al regarding article, "Autoimmune responses to the brain after stroke are associated with worse outcome".
Urra X, Planas AM, Chamorro A. Urra X, et al. Among authors: chamorro a. Stroke. 2012 Feb;43(2):e26; author reply e27-8. doi: 10.1161/STROKEAHA.111.643460. Epub 2012 Jan 5. Stroke. 2012. PMID: 22223242 No abstract available.
Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke.
Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH. Chamorro A, et al. Stroke. 2002 Apr;33(4):1048-52. doi: 10.1161/hs0402.105927. Stroke. 2002. PMID: 11935059
A logistic regression adjusted for confounders confirmed the following independent (odds ratio, 95% CI) good outcome predictors: age (0.97, 0.96 to 0.99), Mathew score on admission (1.14, 1.12 to 1.17), erythrocyte sedimentation rate (0.98, 0.97 to 0.99), infarction volume
A logistic regression adjusted for confounders confirmed the following independent (odds ratio, 95% CI) good outcome predictors: age
Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke.
Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro A. Vila N, et al. Among authors: chamorro a. Stroke. 2003 Mar;34(3):671-5. doi: 10.1161/01.STR.0000057976.53301.69. Epub 2003 Feb 20. Stroke. 2003. PMID: 12624290 Clinical Trial.
Anti-inflammatory cytokines act in a feedback loop to inhibit continued proinflammatory cytokine production. We assessed the implication of interleukin (IL)-10 and IL-4 in deteriorating ischemic stroke. ...
Anti-inflammatory cytokines act in a feedback loop to inhibit continued proinflammatory cytokine production. We assessed the implicat …
The harms and benefits of inflammatory and immune responses in vascular disease.
Chamorro A, Hallenbeck J. Chamorro A, et al. Stroke. 2006 Feb;37(2):291-3. doi: 10.1161/01.STR.0000200561.69611.f8. Epub 2006 Jan 12. Stroke. 2006. PMID: 16410468 Free PMC article. Review. No abstract available.
Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression.
Chamorro A, Urra X, Planas AM. Chamorro A, et al. Stroke. 2007 Mar;38(3):1097-103. doi: 10.1161/01.STR.0000258346.68966.9d. Epub 2007 Jan 25. Stroke. 2007. PMID: 17255542 Review.
However, it is controversial whether infections promote neurological worsening or alternatively represent a marker of severe disease. ...Overall, a better understanding of the cross-talk between the brain and the immune system might lead to more effective therapies …
However, it is controversial whether infections promote neurological worsening or alternatively represent a marker of severe disease. …
A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A. Amaro S, et al. Among authors: chamorro a. Stroke. 2007 Jul;38(7):2173-5. doi: 10.1161/STROKEAHA.106.480699. Epub 2007 May 24. Stroke. 2007. PMID: 17525395 Clinical Trial.
METHODS: Using a double-blind design, we assessed the safety of exogenous UA in patients with acute stroke treated with rt-PA. ...The clinical efficacy of dual administration of exogenous UA and rt-PA deserves further investigation in a larger acute stroke trial....
METHODS: Using a double-blind design, we assessed the safety of exogenous UA in patients with acute stroke treated with rt-PA. ...The …
Stroke-induced immunodepression is a marker of severe brain damage.
Urra X, Chamorro A. Urra X, et al. Among authors: chamorro a. Stroke. 2010 Feb;41(2):e110; author reply e111. doi: 10.1161/STROKEAHA.109.566968. Epub 2009 Dec 24. Stroke. 2010. PMID: 20035073 No abstract available.
Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke.
San Román L, Obach V, Blasco J, Macho J, Lopez A, Urra X, Tomasello A, Cervera A, Amaro S, Perandreu J, Branera J, Capurro S, Oleaga L, Chamorro A. San Román L, et al. Among authors: chamorro a. Stroke. 2012 Jun;43(6):1657-9. doi: 10.1161/STROKEAHA.111.640011. Epub 2012 Mar 22. Stroke. 2012. PMID: 22442176 Clinical Trial.
METHODS: We conducted a prospective, single-center study of 60 patients (mean age, 71.3 years; male 47%) with stroke lasting <8 hours in the anterior circulation (n=54) or <12 hours in the vertebrobasilar circulation (n=6) treated if CT perfusion/CT angiography confi …
METHODS: We conducted a prospective, single-center study of 60 patients (mean age, 71.3 years; male 47%) with stroke lasting <8 ho …
Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation.
Strbian D, Seiffge DJ, Breuer L, Numminen H, Michel P, Meretoja A, Coote S, Bordet R, Obach V, Weder B, Jung S, Caso V, Curtze S, Ollikainen J, Lyrer PA, Eskandari A, Mattle HP, Chamorro A, Leys D, Bladin C, Davis SM, Köhrmann M, Engelter ST, Tatlisumak T. Strbian D, et al. Among authors: chamorro a. Stroke. 2013 Oct;44(10):2718-21. doi: 10.1161/STROKEAHA.113.002033. Epub 2013 Aug 8. Stroke. 2013. PMID: 23929752 Clinical Trial.
We aimed to validate the score in a large multicenter cohort in anterior and posterior circulation. METHODS: Prospectively collected data of consecutive ischemic stroke patients who received intravenous thrombolysis in 12 stroke centers were merged (n=5471). ...
We aimed to validate the score in a large multicenter cohort in anterior and posterior circulation. METHODS: Prospectively collected …
Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?
Strbian D, Ringleb P, Michel P, Breuer L, Ollikainen J, Murao K, Seiffge DJ, Jung S, Obach V, Weder B, Eskandari A, Gensicke H, Chamorro A, Mattle HP, Engelter S, Leys D, Numminen H, Köhrmann M, Hacke W, Tatlisumak T. Strbian D, et al. Among authors: chamorro a. Stroke. 2013 Oct;44(10):2913-6. doi: 10.1161/STROKEAHA.111.000819. Epub 2013 Aug 22. Stroke. 2013. PMID: 23970791 Clinical Trial.
BACKGROUND AND PURPOSE: We previously reported increased benefit and reduced mortality after ultra-early stroke thrombolysis in a single center. ...RESULTS: In the whole cohort (n=6856), shorter onset-to-treatment time as a continuous variable was significantly asso …
BACKGROUND AND PURPOSE: We previously reported increased benefit and reduced mortality after ultra-early stroke thrombolysis in a sin …
392 results
Jump to page
Feedback